Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal Dexmedetomidine in Severe COPD
NCT02773797Phase 4Withdrawn
- Sponsor
- Dayton VA Medical Center
- Start
- Aug 2016
- Primary completion
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dexmedetomidine in chronic obstructive pulmonary disease (COPD), sponsored by Dayton VA Medical Center. Planned start Aug 2016; status: withdrawn.
02
Drugs
dexmedetomidine
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT02773797.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02773797.